← Back to Search

Behavioral Intervention

Mobile Text Messaging Support for Smoking Cessation

N/A
Waitlist Available
Led By Patricia Chalela, DrPH
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month and 3 months
Awards & highlights

Study Summary

This trial aims to evaluate a tailored texting program to help young Latinos quit smoking. Results will show if it increases quit rates & reduce smoking-related illnesses & healthcare costs.

Who is the study for?
This study is for Latino young adults aged 18-29 who smoke at least one cigarette a day, want to quit smoking, own a cell phone with text and internet capabilities, and can provide follow-up data. They should not be in another cessation program or planning to move from the study area during the trial.Check my eligibility
What is being tested?
The Quitxt research study tests a mobile text messaging intervention designed to help young Latino adults stop smoking. Participants are randomly assigned to receive either interactive Quitxt messages or standard texts with cessation content plus referral to an existing state health service program.See study design
What are the potential side effects?
Since this trial involves text messaging interventions for smoking cessation rather than medication, there are no direct medical side effects. However, participants may experience typical nicotine withdrawal symptoms such as irritability, cravings, or difficulty concentrating.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month and 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Smoking cessation
Secondary outcome measures
Smoking cessation assessment

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual careExperimental Treatment1 Intervention
Abbreviated text messaging with smoking cessation-related content and referral to the Texas Department of State Health Services (TDSHS) cessation program Yes Quit (www.yesquit.org) available to smokers seeking help quitting. The abbreviated text messaging will include general information on smoking harms and benefits of cessation, and baseline data collection and follow-up assessments.
Group II: Quitxt bilingual text messaging and chatExperimental Treatment1 Intervention
Culturally and linguistically tailored, bilingual text messaging or chat mobile app. Our text messaging or chat intervention will include messaging options in which users can text or message a code when they are craving a cigarette or at risk of relapse and immediately receive text or social media messages to help them avoid smoking. The social media content also will include opportunities for users to repeatedly visit key content pages and receive immediate support when experiencing cravings, stress, bad mood, or when feeling at risk of smoking.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
453 Previous Clinical Trials
90,230 Total Patients Enrolled
Cancer Prevention Research Institute of TexasOTHER
50 Previous Clinical Trials
97,238 Total Patients Enrolled
The University of Texas at San AntonioOTHER
22 Previous Clinical Trials
6,304 Total Patients Enrolled

Media Library

Quitxt (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05958667 — N/A
Smoking Cessation Research Study Groups: Quitxt bilingual text messaging and chat, Usual care
Smoking Cessation Clinical Trial 2023: Quitxt Highlights & Side Effects. Trial Name: NCT05958667 — N/A
Quitxt (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05958667 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experimental research permit the involvement of senior citizens?

"The inclusion parameters for this exploratory research mandates that the minimum age of participants is 18 years old, with a maximum age limit set at 29."

Answered by AI

Who is allowed to participate in this clinical experimentation?

"In order to be considered for this medical trial, potential participants should have recently quit smoking and must lie between 18-29 years old. 1200 volunteers are being enrolled in the study."

Answered by AI

Are individuals currently eligible to apply for this research endeavor?

"Unfortunately, according to the records on clinicaltrials.gov, recruitment for this particular trial closed in July of 2023 and is no longer enrolling candidates. However, there are currently 141 other studies that are actively accepting participants."

Answered by AI

Who else is applying?

What site did they apply to?
The University of Texas Health Science Center at San Antonio
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Quitxt Mobile Text Messaging Cessation Research Study
Patricia Chalela 2024. "Quitxt Mobile Text Messaging Cessation Research Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05958667.
~800 spots leftby Aug 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top